Biotech Values

[si39]

Acuitas announced they provided LNP technology used by BNTX,
https://acuitastx.com/wp-content/uploads/2020/07/Acuitas-News-Release-July-1-2020-1.pdf
"In a further twist, Acuitas is the source of the LNPs that Biontech and Pfizer use in BNT162b1. This arrangement appears to have been routed through a deal between Biontech and Genevant, a venture founded jointly in April 2018 by Arbutus and Vivek Ramaswamy’s holding company, Roivant Sciences." -https://www.evaluate.com/vantage/articles/news/patents-and-litigation/covid-19-vaccine-battle-just-got-interesting

Acuitas had licensed ABUS technology in the past,

Arbutus Settles Litigation, Terminating Acuitas’ Rights to LNP Technology
https://www.globenewswire.com/news-release/2018/02/22/1380322/0/en/Arbutus-Settles-Litigation-Terminating-Acuitas-Rights-to-LNP-Technology.html